Tariffs and federal research “uncertainty” are forcing a Peninsula company to lay off workers at headquarters and cut other ...

By Sneha S K (Reuters) -Gene sequencing equipment maker PacBio plans to cut around 120 jobs and lower expenses due to fresh ...

Bernstein analyst Eve Burstein lowered the firm’s price target on PacBio (PACB) to $1.50 from $2 and keeps an Outperform rating on the shares.

Rady study uses PacBio long-read sequencing for RFX3 variant in adolescent patient with autism, showcasing clinical genomics ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...

Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. | Looking to ...

Tariffs and federal research “uncertainty” are forcing this Menlo Park biotech company to lay off workers at headquarters and ...

US sequencing firm PacBio (Nasdaq: PACB) is cutting jobs and reducing spending across its business as it braces for the financial impact of new global tariffs and growing uncertainty around federal ...

Shares of Pacific Biosciences of California climbed after the company backed its prior outlook and announced cuts to its spending and workforce. The stock rose 9.6% to $1.32 in mid-morning trading.

A major new initiative was launched on Tuesday (15 April) by the Wellcome Sanger Institute in collaboration with Pacific ...

In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report), with a ...

April 9 (Reuters) - Gene sequencing equipment maker PacBio (PACB.O), opens new tab plans to cut around 120 jobs and lower expenses due to fresh tariffs and reduced funding for federal health ...